Author Question: The indicators the nurse would find useful for evaluation of outcomes relating to sleep improvement ... (Read 55 times)

strangeaffliction

  • Hero Member
  • *****
  • Posts: 660
The indicators the nurse would find useful for evaluation of outcomes relating to sleep improvement
  include (more than one answer may be correct)
 
  A. fewer than 5 hours of sleep.
  B. decreased time falling asleep.
  C. fewer awakenings.
  D. dependence on sleep aids.
  E. ability to resume sleep after awakening.
  F. client perception of improvement.

Question 2

A client being treated on an outpatient basis for generalized anxiety disorder reports I have a little
  difficulty falling asleep but then I sleep soundly for about 7 hours.
 
  I do not worry excessively about
  what is going on in my life anymore, and I'm able to enjoy spending time with friends and relatives.
  For the past 3 weeks I've been able to use relaxation to stop the episodes of racing pulse and
  thinking I'm going to die.. The nurse should evaluated the outcome, anxiety self-control, as
  a. seldom demonstrated.
  b. sometimes demonstrated.
  c. often demonstrated.
  d. consistently demonstrated.



yeungji

  • Sr. Member
  • ****
  • Posts: 319
Answer to Question 1

B, C, E, F
Rationale: Options B, C, E, and F suggest normalization of sleep. Option A refers to an amount of
sleep generally thought to be insufficient. Option D: Normalization of sleep should not depend on
use of sleep aids.

Answer to Question 2

ANS: D
Being able to consistently control the anxiety response (e.g., elevated blood pressure, pulse,
respiration, dilated pupils, sweating) is the most definitive indicator of anxiety self-control.
Adequate nightly sleep and maintenance of social relationships also suggest the client is making
progress toward anxiety self-control. Lack of exaggerated concerns about life events is also an
indicator of decreased anxiety.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

For a complete list of videos, visit our video library